T43.602D Poisoning by unspecified psychostimulants, intentional self-harm, subsequent encounter

Name of the Condition

• Poisoning by unspecified psychostimulants, intentional self-harm, subsequent encounter

Summary

This condition represents a subsequent encounter for poisoning by unspecified psychostimulants, where the exposure was intentional self-harm. It requires ongoing medical evaluation and management following initial treatment. Psychostimulants are substances that increase alertness or energy, and "unspecified" indicates the specific agent is not identified. The "subsequent encounter" modifier denotes care during the recovery phase after the acute event.

Causes

Intentional self-harm poisoning may result from deliberate ingestion or exposure to psychostimulants, including prescription medications, illicit drugs, or over-the-counter stimulants. The act is driven by suicidal intent or self-injurious behavior, with the specific stimulant type remaining unidentified.

Risk Factors

• History of mental health conditions (e.g., depression, anxiety, or suicidal ideation).
• Prior substance use disorders or self-harm behaviors.
• Access to psychostimulant medications or illicit stimulants.
• Social or environmental stressors contributing to self-harm.

Symptoms

• Agitation, restlessness, or severe anxiety.
• Tachycardia, hypertension, or palpitations.
• Tremors, muscle spasms, or seizures.
• Nausea, vomiting, or abdominal pain.
• Confusion, hallucinations, or altered mental status.
• Excessive sweating, fever, or respiratory distress.

Diagnosis

Diagnosis relies on patient history (including self-harm intent), clinical presentation, and toxicology screening. Documentation must confirm intentional self-harm and specify the encounter as subsequent. Clinical evaluation assesses residual toxicity, organ function, and mental health status.

Treatment Options

Treatment focuses on managing residual symptoms, preventing recurrence, and addressing underlying mental health needs. Interventions may include:

• Monitoring for delayed toxicity or complications.
• Pharmacologic management of symptoms (e.g., anticonvulsants, anxiolytics).
• Referral to mental health or substance use disorder specialists.
• Safety planning and crisis intervention.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, comorbidities, and adherence to follow-up care. Subsequent encounters require ongoing assessment of mental health stability and risk of reoccurrence. Regular follow-up with mental health providers is critical to reduce future self-harm incidents.

Complications

• Persistent psychiatric symptoms (e.g., depression, anxiety).
• Cardiovascular or neurological damage from stimulant toxicity.
• Recurrent self-harm or suicidal behavior.
• Substance use disorder development or exacerbation.

Lifestyle & Prevention

• Secure storage of psychostimulant medications to limit access.
• Engagement in mental health therapy or support groups.
• Development of coping strategies for stress or suicidal thoughts.
• Avoidance of triggers or environments associated with self-harm.

When to Seek Professional Help

Seek immediate care if symptoms worsen, new complications arise, or suicidal thoughts return. Ongoing mental health support is essential for recovery and prevention of future incidents.

Tips for Medical Coders

Document the intentional self-harm context and subsequent encounter status clearly. Ensure the code T43.602D is used only when the poisoning is confirmed as intentional self-harm and the encounter occurs after the acute phase of treatment. Verify that "unspecified" psychostimulants are appropriately documented when the agent is unknown.